Autoinflammatory diseases
Autoinflammatory diseases are disorders of the innate immune system characterized by recurrent systematic inflammation and serious complications. Dysregulation of inflammasome and overproduction of interleukin-1 play a major role in the pathogenesis of autoinflammatory diseases. The diagnosis of these rare conditions rely on recognising the pattern of presentation and differential diagnosis. Manifestations may include fever, rash, serositis (pleuritis and peritonitis), arthritis, meningitis and uveitis. Secondary amyloidosis may complicate longstanding disease. Advances in our understanding of the molecular and pathophysiological basis of the autoinflammatory diseases have resulted in new treatment strategies. Early diagnosis and effective therapy are critical to prevent irreversible organ damage. The purpose of this review is to describe the major clinical, genetic, and therapeutic features of the most common autoinflammatory syndromes. Orv Hetil. 2018; 159(23): 898-907.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:159 |
|---|---|
| Enthalten in: |
Orvosi hetilap - 159(2018), 23 vom: 10. Juni, Seite 898-907 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Autoinflammatiós kórképek |
|---|
| Beteiligte Personen: |
Mosdósi, Bernadett [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoinflammatiós kórképek |
|---|
| Anmerkungen: |
Date Completed 13.08.2018 Date Revised 13.08.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1556/650.2018.31068 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM285060317 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM285060317 | ||
| 003 | DE-627 | ||
| 005 | 20231225044553.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.1556/650.2018.31068 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0950.xml |
| 035 | |a (DE-627)NLM285060317 | ||
| 035 | |a (NLM)29860887 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Mosdósi, Bernadett |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Autoinflammatory diseases |
| 246 | 3 | 3 | |a Autoinflammatiós kórképek |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.08.2018 | ||
| 500 | |a Date Revised 13.08.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Autoinflammatory diseases are disorders of the innate immune system characterized by recurrent systematic inflammation and serious complications. Dysregulation of inflammasome and overproduction of interleukin-1 play a major role in the pathogenesis of autoinflammatory diseases. The diagnosis of these rare conditions rely on recognising the pattern of presentation and differential diagnosis. Manifestations may include fever, rash, serositis (pleuritis and peritonitis), arthritis, meningitis and uveitis. Secondary amyloidosis may complicate longstanding disease. Advances in our understanding of the molecular and pathophysiological basis of the autoinflammatory diseases have resulted in new treatment strategies. Early diagnosis and effective therapy are critical to prevent irreversible organ damage. The purpose of this review is to describe the major clinical, genetic, and therapeutic features of the most common autoinflammatory syndromes. Orv Hetil. 2018; 159(23): 898-907 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a autoinflammatiós kórképek | |
| 650 | 4 | |a autoinflammatory disorders | |
| 650 | 4 | |a fever | |
| 650 | 4 | |a inflammasoma | |
| 650 | 4 | |a inflammasome | |
| 650 | 4 | |a interleukin-1 | |
| 650 | 4 | |a láz | |
| 700 | 1 | |a Tóth, Beáta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orvosi hetilap |d 1949 |g 159(2018), 23 vom: 10. Juni, Seite 898-907 |w (DE-627)NLM000021601 |x 1788-6120 |7 nnns |
| 773 | 1 | 8 | |g volume:159 |g year:2018 |g number:23 |g day:10 |g month:06 |g pages:898-907 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1556/650.2018.31068 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 159 |j 2018 |e 23 |b 10 |c 06 |h 898-907 | ||